Lawrence Klein is the founder of CRISPR Therapeutics. CRISPR Therapeutics has raised $25M in total funding. Latest round: Series A.
Lawrence Klein is the CEO and a board member at Oruka Therapeutics. Before joining Oruka, he was a Partner at Versant Ventures. He also served as Chief Business Officer and later Chief Operating Officer at CRISPR Therapeutics for seven years, contributing to the company's growth, partnerships, and strategic direction.
Full founder directory · Investor directory · Company funding database · Fundraising library